CARABOODA, Western Australia, Sept. 14, 2017 /Weed Wire/ — AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) is pleased to announce it has appointed three Medical Liaison Managers (MLMs), to manage doctor communications and assist in the prescription of AusCann’s cannabinoid medicines in Australia.
Tag Archives: Medicines
The Auscann Group Holdings Ltd share price has continued its strong run and is up a further 6% to 46 cents today. Why has it jumped? Let’s look to find out.
Unlike GW Pharmaceuticals and Zynerba Pharmaceuticals, which rely on cannabinoid-based medicines to fill out the entirety of their drug-development pipelines, Arena Pharmaceuticals is one of the drug developers that have some of their pipelines devoted to cannabinoid-type therapeutics or CB agonists and other portions devoted to non-cannabinoid medicines.
NEW YORK, Oct. 20, 2016 /Weed Wire/ — Columbia Care LLC (“CC”), a leading national medical marijuana product development, manufacturing and distribution company, today announced the launch of its line of controlled-dose, solid-fill medical cannabinoid capsules.
DELAVAN, Ill., Nov. 8, 2015 /PRNewswire/ — For the first time in history, high quality medical cannabis is legally available in Illinois. Revolution Cannabis- Delavan, a producer of superior quality medical cannabis, is proud to announce registered patients and caregivers can purchase its products at licensed Illinois dispensaries beginning Monday, November 9, 2015.